Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-26 @ 2:11 AM
Study NCT ID:
NCT06914505
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-06
First Post:
2025-03-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study on the Effectiveness and Safety of VRT in Patients With Visual Field Defects
Sponsor:
Xuanwu Hospital, Beijing
Organization:
Study Overview
Official Title:
Study on the Effectiveness and Safety of Visual Restoration Therapy in the Active Rehabilitation of Patients With Visual Field Defects
Status:
NOT_YET_RECRUITING
Status Verified Date:
2025-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to learn if visual restoration therapy (VRT) (a type of treatment that aims to improve vision) works to the visual rehabilitation of patients with visual field defects. It will also learn about the safety of VRT. The main questions it aims to answer are:
* Can visual reconstruction therapy help expand the visual field in patients with visual field defects?
* What medical problems do patients with visual field defects experience during the procedure of VRT? Researchers will look at how patients with visual field defects who use a visual aid in combination with VRT and those who use a visual aid only, compare the visual field expansion at three months to see how well visual reconstruction therapy works.
Participants will:
* will undergo a specialized visual function assessment and be provided with a pair of appropriate vision aids.
* Visit the clinic at one month and three months after enrolment for review of visual function and completion of a Chinese-version Low Vision Quality of Life (CLVQOL) questionnaire.
* Participants receiving VRT will additionally undergo 30 minutes of VRT three times per week for 3 months.
* Keep a diary for their symptoms and severity and frequency of occurrence during treatment.
* Can visual reconstruction therapy help expand the visual field in patients with visual field defects?
* What medical problems do patients with visual field defects experience during the procedure of VRT? Researchers will look at how patients with visual field defects who use a visual aid in combination with VRT and those who use a visual aid only, compare the visual field expansion at three months to see how well visual reconstruction therapy works.
Participants will:
* will undergo a specialized visual function assessment and be provided with a pair of appropriate vision aids.
* Visit the clinic at one month and three months after enrolment for review of visual function and completion of a Chinese-version Low Vision Quality of Life (CLVQOL) questionnaire.
* Participants receiving VRT will additionally undergo 30 minutes of VRT three times per week for 3 months.
* Keep a diary for their symptoms and severity and frequency of occurrence during treatment.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: